Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-12 Purchase | 2023-04-14 06:00 am | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 25,000 | $0.29 | $7,250 | 106,901 (Direct) | View |
| 2022-01-27 Purchase | 2022-01-31 4:00 pm | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 13,500 | $1.7244 | $23,280 | 44,867 (Direct) | View |
| 2021-06-11 Purchase | 2021-06-15 6:00 pm | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 1,500 | $5.45 | $8,175 | 1,500 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-14 Option Award | 2024-02-15 6:00 pm | N/A 2034-02-14 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 14,200 | $0 | 14,200 (Direct) | View |
| 2024-01-03 Tax Withholding | 2024-01-05 4:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 11,838 | $0.4961 | 84,758 (Direct) | View |
| 2023-10-02 Disposition | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 359,269 | $0 | 594,269 (Direct) | View |
| 2023-10-02 Option Award | 2023-10-04 5:01 pm | N/A 2031-04-29 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 594,269 | $0 | 594,269 (Direct) | View |
| 2023-07-03 Tax Withholding | 2023-07-05 6:59 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 10,305 | $0.36 | 96,596 (Direct) | View |
| 2023-02-21 Option Award | 2023-02-23 8:01 pm | N/A 2033-02-21 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 210,000 | $0 | 210,000 (Direct) | View |
| 2023-01-03 Tax Withholding | 2023-01-05 6:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 6,091 | $1.02 | 81,901 (Direct) | View |
| 2022-07-28 Option Award | 2022-08-01 6:22 pm | N/A 2032-07-28 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 71,875 | $0 | 116,742 (Direct) | View |
| 2022-01-20 Option Award | 2022-01-24 4:00 pm | N/A 2032-01-20 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 55,519 | $0 | 55,519 (Direct) | View |
| 2022-01-03 Option Award | 2022-01-05 7:00 pm | N/A N/A | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 29,867 | $0 | 31,367 (Direct) | View |
Ownership | 2021-05-27 6:06 pm | N/A 2031-04-12 | Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary | 0 | $0 | 300,000 (Direct) | View |
| 2021-03-15 Option Award | 2021-03-17 5:00 pm | N/A 2031-03-15 | Lineage Cell Therapeutics Inc. | LCTX | Leavitt Chase C. General Counsel/Secretary | 699,100 | $0 | 699,100 (Direct) | View |
| 2020-03-17 Option Award | 2020-03-19 5:00 pm | N/A 2030-03-17 | Lineage Cell Therapeutics Inc. | LCTX | Leavitt Chase C. General Counsel/Secretary | 616,700 | $0 | 616,700 (Direct) | View |